Mangafodipir trisodium

The trisodium salt of mangafodipir with potential antioxidant and chemoprotective activities. Consisting of manganese (II) ions chelated to fodipir… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Hepatobiliary-specific contrast agents are one of several classes of contrast agents available for magnetic resonance (MR… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2004
2004
OBJECTIVE This study was designed to determine whether the addition of mangafodipir trisodium-enhanced MRI could improve the… (More)
Is this relevant?
2002
2002
OBJECTIVE The purpose of this study was to compare mangafodipir trisodium-enhanced MR imaging performed with a phased array coil… (More)
Is this relevant?
2002
2002
OBJECTIVE The purpose of our study was to assess the usefulness of mangafodipir trisodium-enhanced MR cholangiography for… (More)
Is this relevant?
1999
1999
The aim of this work was to study the ability of mangafodipir trisodium (Mn-DPDP)-enhanced MR imaging in differentiating… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1998
1998
The purpose of the study was to investigate retrospectively whether mangafodipir trisodium (MnDPDP) can enhance the liver… (More)
Is this relevant?
1998
1998
Inflammatory pseudotumor of the liver is a rare benign mass that is often misdiagnosed as hepatocellular carcinoma at… (More)
Is this relevant?
1996
1996
PURPOSE To determine the efficacy of manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) at… (More)
Is this relevant?
1995
1995
Mangafodipir trisodium (MnDPDP) is a manganese chelate being developed as a contrast agent for magnetic resonance imaging of the… (More)
Is this relevant?